Recent News: View News Archive
AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016
AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016
June 20, 2013
Pharmaceutical giant AstraZeneca has announced it is setting up its new global headquarters at the Cambridge Biomedical Campus. The 330m research and development (R&D) site is expected to employ about 2,000 people and open by 2016. The company will cease R&D at Alderley Park in Cheshire and close its London HQ. The majority of posts will move to Cambridge, but 700 jobs are being axed. The new site will become AstraZeneca's largest centre for cancer research. It will also focus on cardiovascular, metabolic, respiratory, inflammation and autoimmune disease research
Quick Search:
Use drop down menu to quickly view available jobs in your field of expertise
Featured Listing:
Process Development: Principal Scientist
Location: Mid Atlantic